[HTML][HTML] Determinants of the onset and prognosis of the post-COVID-19 condition: a 2-year prospective observational cohort study
Summary Background At least 5–10% of subjects surviving COVID-19 develop the post-
COVID-19 condition (PCC) or" Long COVID". The clinical presentation of PCC is …
COVID-19 condition (PCC) or" Long COVID". The clinical presentation of PCC is …
[HTML][HTML] Determinants of the onset and prognosis of the post-COVID-19 condition: a 2-year prospective observational cohort study
L Mateu, C Tebe, C Loste, JR Santos… - The Lancet Regional …, 2023 - thelancet.com
Summary Background At least 5–10% of subjects surviving COVID-19 develop the post-
COVID-19 condition (PCC) or" Long COVID". The clinical presentation of PCC is …
COVID-19 condition (PCC) or" Long COVID". The clinical presentation of PCC is …
Determinants of the onset and prognosis of the post-COVID-19 condition: a 2-year prospective observational cohort study
L Mateu, C Tebe, C Loste, JR Santos… - The Lancet …, 2023 - pubmed.ncbi.nlm.nih.gov
Background At least 5-10% of subjects surviving COVID-19 develop the post-COVID-19
condition (PCC) or" Long COVID". The clinical presentation of PCC is heterogeneous, its …
condition (PCC) or" Long COVID". The clinical presentation of PCC is heterogeneous, its …
[HTML][HTML] Determinants of the onset and prognosis of the post-COVID-19 condition: a 2-year prospective observational cohort study
L Mateu, C Tebe, C Loste, JR Santos… - The Lancet Regional …, 2023 - ncbi.nlm.nih.gov
Background At least 5–10% of subjects surviving COVID-19 develop the post-COVID-19
condition (PCC) or “Long COVID”. The clinical presentation of PCC is heterogeneous, its …
condition (PCC) or “Long COVID”. The clinical presentation of PCC is heterogeneous, its …
[PDF][PDF] Determinants of the onset and prognosis of the post-COVID-19 condition: a 2-year prospective observational cohort study
L Mateu, C Tebe, C Loste, JR Santos, G Lladós… - Health, 2023 - researchgate.net
Summary Background At least 5–10% of subjects surviving COVID-19 develop the post-
COVID-19 condition (PCC) or “Long COVID”. The clinical presentation of PCC is …
COVID-19 condition (PCC) or “Long COVID”. The clinical presentation of PCC is …
Determinants of the Onset and Prognosis of the Post-COVID-19 Condition: A 2-Year Prospective Cohort Study
L Mateu, C Tebe, C Loste, JR Santos, G Lladós… - papers.ssrn.com
Background: At least 5-10% of subjects surviving COVID-19 develop the post-COVID-19
condition (PCC) or “Long COVID”. The clinical presentation of PCC is heterogeneous, its …
condition (PCC) or “Long COVID”. The clinical presentation of PCC is heterogeneous, its …
Determinants of the onset and prognosis of the post-COVID-19 condition: a 2-year prospective observational cohort study
L Mateu, C Tebe, C Loste, J Santos… - The Lancet Regional …, 2023 - europepmc.org
Background At least 5–10% of subjects surviving COVID-19 develop the post-COVID-19
condition (PCC) or “Long COVID”. The clinical presentation of PCC is heterogeneous, its …
condition (PCC) or “Long COVID”. The clinical presentation of PCC is heterogeneous, its …
[PDF][PDF] Determinants of the onset and prognosis of the post-COVID-19 condition: a 2-year prospective observational cohort study
L Mateu, C Tebe, C Loste, JR Santos, G Lladós… - Health, 2023 - blog.fdik.org
Summary Background At least 5–10% of subjects surviving COVID-19 develop the post-
COVID-19 condition (PCC) or “Long COVID”. The clinical presentation of PCC is …
COVID-19 condition (PCC) or “Long COVID”. The clinical presentation of PCC is …
[HTML][HTML] Determinants of the onset and prognosis of the post-COVID-19 condition: a 2-year prospective observational cohort study
L Mateu, C Tebe, C Loste, JR Santos, G Lladós… - The Lancet Regional …, 2023 - Elsevier
Summary Background At least 5–10% of subjects surviving COVID-19 develop the post-
COVID-19 condition (PCC) or “Long COVID”. The clinical presentation of PCC is …
COVID-19 condition (PCC) or “Long COVID”. The clinical presentation of PCC is …
Determinants of the onset and prognosis of the post-COVID-19 condition: a 2-year prospective observational cohort study.
L Mateu, C Tebe, C Loste, JR Santos… - The Lancet Regional …, 2023 - europepmc.org
Background At least 5-10% of subjects surviving COVID-19 develop the post-COVID-19
condition (PCC) or" Long COVID". The clinical presentation of PCC is heterogeneous, its …
condition (PCC) or" Long COVID". The clinical presentation of PCC is heterogeneous, its …